Dhruv Kazi
Academic Appointments
- Postdoctoral Research fellow, Health Research & Policy
Key Documents
Contact Information
- Academic Offices
Personal Information Email
Professional Overview
Professional Education
| Master of Science: | Stanford University, HSR-MS (2012) |
| Master of Science: | Stanford University, Health Services Research (2012) |
| -: | d.school, Stanford University, Design for Extreme Affordability (2012) |
| -: | Stanford University Graduate School of Business, Program in Innovation and Entrepreneurship (2011) |
| -: | University of California, San Diego, Cardiovascular Medicine Fellowship (2010) |
| Master of Science: | London School of Economics, London, UK, International Health Policy and Health Economics (2007) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
I am a general cardiologist and a cardiovascular health economist interested in understanding and improving long-term clinical outcomes among patients with cardiovascular disease in the United States and overseas.
My recent work has involved the evaluation of novel diagnostic approaches, medical devices, drug therapy and genetic testing. I am particularly interested in the process of optimizing health care priority setting in low-resource settings. For instance, how does one determine the "best" use for scarce resources when considering alternative strategies for a given disease or a range of commonly encountered diseases? Is there a common framework for decision analysis that would be relevant to both the American health care system as well as to South Asia?
I aspire to leverage my dual training in cardiology and health economics to help ensure that our investments in healthcare represent true societal value.
Publications
- Atrial fibrillation ablation, symptoms, and stroke risk: comment on "Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF)". JAMA Intern Med. 2013; (2): 156-7
- Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J. 2013; (5): 800-808.e2
- Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med. 2013; (10): 727-34
- The economics of heart failure. Heart Fail Clin. 2013; (1): 93-106
- Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012; (12): 2042-9
- Repeat revascularization is a faulty end point for clinical trials. Circ Cardiovasc Qual Outcomes. 2012; (3): 249-50
Help